Best Practices in Dengue Surveillance: A Report from the Asia-Pacific and Americas Dengue Prevention Boards

被引:154
作者
Beatty, Mark E. [1 ]
Stone, Amy [2 ]
Fitzsimons, David W. [3 ]
Hanna, Jeffrey N. [4 ]
Lam, Sai Kit [4 ]
Vong, Sirenda [4 ]
Guzman, Maria G. [4 ]
Mendez-Galvan, Jorge F. [4 ]
Halstead, Scott B. [1 ]
Letson, G. William [1 ]
Kuritsky, Joel [1 ]
Mahoney, Richard [1 ]
Margolis, Harold S. [1 ]
机构
[1] Int Vaccine Inst, Pediat Dengue Vaccine Initiat, Seoul, South Korea
[2] Amy Stone Sci & Med Commun Inc, Atlanta, GA USA
[3] WHO, Off Director Gen, Off Governing Bodies, Dept Documentat & Commun, CH-1211 Geneva, Switzerland
[4] Int Vaccine Inst, Pediat Dengue Vaccine Initiat, Asia Pacific & Amer Dengue Prevent Boards Surveil, Seoul, South Korea
基金
比尔及梅琳达.盖茨基金会;
关键词
DISEASE SURVEILLANCE; CASE DEFINITIONS; CHALLENGES; PHYSICIANS; DIAGNOSIS; RESPONSES; OUTBREAKS; NEED;
D O I
10.1371/journal.pntd.0000890
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Dengue fever is a virus infection that is spread by the Aedes aegypti mosquito and can cause severe disease especially in children. Dengue fever is a major problem in tropical and sub-tropical regions of the world. Methodology/Principal Findings: We invited dengue experts from around the world to attend meetings to discuss dengue surveillance. We reviewed literature, heard detailed reports on surveillance programs, and shared expert opinions. Results: Presentations by 22 countries were heard during the 2.5 day meetings. We describe the best methods of surveillance in general, the stakeholders in dengue surveillance, and the steps from mosquito bite to reporting of a dengue case to explore how best to carry out dengue surveillance. We also provide details and a comparison of the dengue surveillance programs by the presenting countries. Conclusions/Significance: The experts provided recommendations for achieving the best possible data from dengue surveillance accepting the realities of the real world (e. g., limited funding and staff). Their recommendations included: (1) Every dengue endemic country should make reporting of dengue cases to the government mandatory; (2) electronic reporting systems should be developed and used; (3) at minimum dengue surveillance data should include incidence, hospitalization rates, deaths by age group; (4) additional studies should be completed to check the sensitivity of the system; (5) laboratories should share expertise and data; (6) tests that identify dengue virus should be used in patients with fever for four days or less and antibody tests should be used after day 4 to diagnose dengue; and (7) early detection and prediction of dengue outbreaks should be goals for national surveillance systems.
引用
收藏
页数:7
相关论文
共 32 条
[1]  
[Anonymous], 2007, DAILY NEWS
[2]  
[Anonymous], 2009, DENG GUID DIAGN TREA
[3]  
[Anonymous], 1997, Dengue hemorrhagic fever: Diagnosis, treatment, prevention and control, V2nd
[4]  
Beatty M.E., 2009, GLOBAL BURDEN DENGUE
[5]   Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections [J].
Chanama, S ;
Anantapreecha, S ;
A-nuegoonpipat, A ;
Sa-gnasang, A ;
Kurane, I ;
Sawanpanyalert, P .
JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (03) :185-189
[6]  
De Paula Sérgio Oliveira, 2004, Braz J Infect Dis, V8, P390
[7]   The WHO dengue classification and case definitions: time for a reassessment [J].
Deen, Jacqueline L. ;
Harris, Eva ;
Wills, Bridget ;
Balmaseda, Angel ;
Hammond, Samantha Nadia ;
Rocha, Crisanta ;
Dung, Nguyen Minh ;
Hung, Nguyen Thanh ;
Hien, Tran Tinh ;
Farrar, Jeremy J. .
LANCET, 2006, 368 (9530) :170-173
[8]  
*DENG PREV BOARDS, 2006, PED DENG VACC IN
[9]   Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries [J].
DeRoeck, D ;
Deen, J ;
Clemens, JD .
VACCINE, 2003, 22 (01) :121-129
[10]   The global emergence/resurgence of arboviral diseases as public health problems [J].
Gubler, DJ .
ARCHIVES OF MEDICAL RESEARCH, 2002, 33 (04) :330-342